ProMIS Neurosciences Inc. Common Shares (ON) (PMN)
PMN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.66
-8.36% on the day
Market cap
$77.7M
Micro cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | PMN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001374339 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | Z4 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-03-25 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy | DEFA14A | 2026-04-09 |
Source: SEC EDGAR submissions feed, 370 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RFL | Rafael Holdings Inc. | $1.49 | -1.97% | $77.5M |
| NTHI | NeOnc Technologies Holdings Inc. | $2.60 | -4.95% | $77.2M |
| INCR | Intercure Ltd. | $5.03 | +1.62% | $75.5M |
| TELO | Telomir Pharmaceuticals Inc. | $1.09 | -0.91% | $80.2M |
| ACRV | Acrivon Therapeutics Inc. | $1.75 | -7.89% | $75.0M |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | $5.95 | -0.50% | $74.9M |
| HRTX | Heron Therapeutics Inc. | $0.3906 | -6.01% | $74.2M |
| MNOV | Medicinova Inc | $1.50 | -2.60% | $73.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier